A Study to Investigate the Safety, Tolerability, and Preliminary Efficacy with AION-301 Administered by Intravenous Infusion Compared with Placebo Administered by Intravenous Infusion Investigational Intervention in Participants Aged 35 to 75 Years of Age with Chronic Kidney Disease (CKD)

PHASE1/PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 23, 2025

Primary Completion Date

January 31, 2026

Study Completion Date

December 31, 2027

Conditions

Chronic Kidney Disease Stage 3

Interventions

BIOLOGICAL

AION-301

AION-301 Infusion

DRUG

Placebo

Placebo Infusion

Trial Locations (1)

RECRUITING

University of Miami, Leonard M. Miller School of Medicine, Miami